Organizing Committee Member
Dr. Hasan Mahmud
CAR-T R&D Scientist
University of Oklahoma
United States of America
Biography
Dr Hasan Mahmud has made substantial contributions to the field of hematology and hematological malignancies last 12 years. Currently, he joined in a CAR-T cells research and development team in a world renounced biotech company in Maryland USA. His recent work at Stephenson Cancer Center, University of Oklahoma, USA focused on B-cell chronic lymphocytic leukemia (CLL) biology and tumor microenvironment. Previously, he served as a Senior Scientist at Pediatric Oncology and Hematology department at University of Groningen, The Netherlands where he identified therapeutic targets for Acute Myeloid Leukemia. Dr. Mahmud completed Ph.D. from the University of Tübingen, Germany where he investigated the mechanism and regulation of erythrocyte suicidal death and its contribution to Anemia. Dr. Mahmud has an extensive documented record of authorship in his field of endeavor. As evidence of this research success, Dr. Mahmud’s work has resulted in 42 peer-reviewed scientific articles and 1 letter to the editor in the most prestigious journals in the field. Dr. Mahmud is regularly conducting peer review for several journals and also serves as a member on the editorial board of the different journals in the field.
Research Area
hematological malignancies, B-cell chronic lymphocytic leukemia (CLL) biology,Tumor microenvironment,Pediatric Oncology